Cap

Zacks Small Cap Analysis – IMNN: IND Utility Submitted for Part 1/2 Trial of Seasonal COVID-19 Vaccine… – Go Well being Professional

by

By David Bautz, PhD NASDAQ:IMNN READ THE FULL IMNN RESEARCH REPORT Enterprise Replace Replace on IMNN-101 Imunon, Inc. (NASDAQ:IMNN) is growing IMNN-101, which is a COVID-19 seasonal vaccine booster primarily based on the corporate’s PlaCCine know-how. It’s a DNA vaccine that addresses quite a lot of limitations of present vaccines, together with the sturdiness of … Read more

Zacks Small Cap Analysis – ENSC Striding Towards Opioid Substitute – Cyber Information

by

By Brad Sorensen, CFA NASDAQ:ENSC READ THE FULL ENSC RESEARCH REPORT Ensysce Biosciences (NASDAQ:ENSC) launched its 2023 annual report and reiterated the constructive outcomes seen all year long that we now have beforehand reported on. Some highlights: • Money ended the yr at $1.1 million however since, as we’ve famous, the corporate has added $2.1 … Read more

x